1,963
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Griflola frondosa (GF) produces significant antidepressant effects involving AMPA receptor activation in mice

, , , , , , & show all
Pages 299-305 | Received 15 May 2016, Accepted 22 Aug 2016, Published online: 10 Dec 2016

References

  • Adachi Y, Okazaki M, Ohno N, Yadomae T. 1994. Enhancement of cytokine production by macrophages stimulated with (1->3)-beta-D-glucan, grifolan (GRN), isolated from Grifola frondosa. Biol Pharm Bull. 17:1554–1560.
  • Alt A, Witkin JM, Bleakman D. 2005. AMPA receptor potentiators as novel antidepressants. Curr Pharm Des. 11:1511–1527.
  • Autry AE, Adachi M, Nosyreva E, Na ES, Los MF, Cheng PF, Kavalali ET, Monteggia LM. 2011. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature. 475:91–95.
  • Bai SK, Lee SJ, Na HJ, Ha KS, Han JA, Lee H, Kwon YG, Chung CK, Kim YM. 2005. β-Carotene inhibits inflammatory gene expression in lipopolysaccharide-stimulated macrophages by suppressing redox-based NF-kappaB activation. Exp Mol Med. 37:323–334.
  • Bao H, Ran P, Zhu M, Sun L, Li B, Hou Y, Nie J, Shan L, Li H, Zheng S, et al. 2016. The prefrontal dectin-1/AMPA receptor signaling pathway mediates the robust and prolonged antidepressant effect of proteo-β-glucan from Maitake. Sci Rep 6:28395
  • Beneyto M, Kristiansen LV, Oni-Orisan A, McCullumsmith RE, Meador-Woodruff JH. 2007. Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders. Neuropsychopharmacology. 32:1888–1902.
  • Bhattacharya A, Derecki NC, Lovenberg TW, Drevets WC. 2016. Role of neuro-immunological factors in the pathophysiology of mood disorders. Psychopharmacology (Berl). 233:1623–1636.
  • Bleakman D, Alt A, Witkin JM. 2007. AMPA receptors in the therapeutic management of depression. CNS Neurol Disord Drug Targets. 6:117–126.
  • Borchers AT, Keen CL, Gershwin ME. 2004. Mushrooms, tumors, and immunity: an update. Exp Biol Med (Maywood). 229:393–406.
  • Borsini F, Meli A. 1988. Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology. 94:147–160.
  • Cryan JF, Mombereau C, Vassout A. 2005a. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev. 29:571–625.
  • Cryan JF, Valentino RJ, Lucki I. 2005b. Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci Biobehav Rev. 29:547–569.
  • Cui J, Chisti Y. 2003. Polysaccharopeptides of Coriolus versicolor: physiological activity, uses, and production. Biotechnol Adv. 21:109–122.
  • Cui FJ, Li Y, Xu YY, Liu ZQ, Huang DM, Zhang ZC, Tao WY. 2007. Induction of apoptosis in SGC-7901 cells by polysaccharide-peptide GFPS1b from the cultured mycelia of Grifola frondosa GF9801. Toxicol Vitro. 21:417–427.
  • Deng G, Lin H, Seidman A, Fornier M, D'Andrea G, Wesa K, Yeung S, Cunningham-Rundles S, Vickers AJ, Cassileth B. 2009. A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects. J Cancer Res Clin Oncol. 135:1215–1221.
  • Douglas RJ, Martin KA. 2007. Mapping the matrix: the ways of neocortex. Neuron. 56:226–238.
  • Duric V, Banasr M, Stockmeier CA, Simen AA, Newton SS, Overholser JC, Jurjus GJ, Dieter L, Duman RS. 2013. Altered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjects. Int J Neuropsychopharmacol. 16:69–82.
  • Farley S, Apazoglou K, Witkin JM, Giros B, Tzavara ET. 2010. Antidepressant-like effects of an AMPA receptor potentiator under a chronic mild stress paradigm. Int J Neuropsychopharmacol. 13:1207–1218.
  • Freudenberg F, Celikel T, Reif A. 2015. The role of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors in depression: central mediators of pathophysiology and antidepressant activity? Neurosci Biobehav Rev. 52:193–206.
  • Ghasemi M, Phillips C, Trillo L, De Miguel Z, Das D, Salehi A. 2014. The role of NMDA receptors in the pathophysiology and treatment of mood disorders. Neurosci Biobehav Rev. 47:336–358.
  • Gould TD, O'Donnell KC, Dow ER, Du J, Chen G, Manji HK. 2008. Involvement of AMPA receptors in the antidepressant-like effects of lithium in the mouse tail suspension test and forced swim test. Neuropharmacology. 54:577–587.
  • Ishibashi K, Miura NN, Adachi Y, Ohno N, Yadomae T. 2001. Relationship between solubility of grifolan, a fungal 1,3-beta-d-glucan, and production of tumor necrosis factor by macrophages in vitro. Biosci Biotechnol Biochem. 65:1993–2000.
  • Kim JH, Na HJ, Kim CK, Kim JY, Ha KS, Lee H, Chung HT, Kwon HJ, Kwon YG, Kim YM. 2008. The non-provitamin A carotenoid, lutein, inhibits NF-kappaB-dependent gene expression through redox-based regulation of the phosphatidylinositol 3-kinase/PTEN/Akt and NF-kappaB-inducing kinase pathways: role of H2O2 in NF-kappaB activation. Free Radic Biol Med. 45:885–896.
  • Kodama N, Komuta K, Sakai N, Nanba H. 2002. Effects of D-fraction, a polysaccharide from Grifola frondosa on tumor growth involve activation of NK cells. Biol Pharm Bull. 25:1647–1650.
  • Kodama N, Murata Y, Nanba H. 2004. Administration of a polysaccharide from Grifola frondosa stimulates immune function of normal mice. J Med Food. 7:141–145.
  • Koike H, Iijima M, Chaki S. 2011. Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression. Behav Brain Res. 224:107–111.
  • Kong E, Sucic S, Monje FJ, Savalli G, Diao W, Khan D, Ronovsky M, Cabatic M, Koban F, Freissmuth M, et al. 2015. STAT3 controls IL6-dependent regulation of serotonin transporter function and depression-like behavior. Sci Rep. 5:9009.
  • Krystal JH, Sanacora G, Blumberg H, Anand A, Charney DS, Marek G, Epperson CN, Goddard A, Mason GF. 2002. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol Psychiatry. 7:S71–S80.
  • Lavi I, Friesem D, Geresh S, Hadar Y, Schwartz B. 2006. An aqueous polysaccharide extract from the edible mushroom Pleurotus ostreatus induces anti-proliferative and pro-apoptotic effects on HT-29 colon cancer cells. Cancer Lett. 244:61–70.
  • Li X, Tizzano JP, Griffey K, Clay M, Lindstrom T, Skolnick P. 2001. Antidepressant-like actions of an AMPA receptor potentiator (LY392098). Neuropharmacology. 40:1028–1033.
  • Liu YN, Peng YL, Liu L, Wu TY, Zhang Y, Lian YJ, Yang YY, Kelley KW, Jiang CL, Wang YX. 2015. TNFalpha mediates stress-induced depression by upregulating indoleamine 2,3-dioxygenase in a mouse model of unpredictable chronic mild stress. Eur Cytokine Netw. 26:15–25.
  • Maeng S, Zarate CA, Jr., Du J, Schloesser RJ, McCammon J, Chen G, Manji HK. 2008. Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol Psychiatry. 63:349–352.
  • Mattila P, Salo-Vaananen P, Konko K, Aro H, Jalava T. 2002. Basic composition and amino acid contents of mushrooms cultivated in Finland. J Agric Food Chem. 50:6419–6422.
  • Mengoni ES, Vichera G, Rigano LA, Rodriguez-Puebla ML, Galliano SR, Cafferata EE, Pivetta OH, Moreno S, Vojnov AA. 2011. Suppression of COX-2, IL-1β and TNF-α expression and leukocyte infiltration in inflamed skin by bioactive compounds from Rosmarinus officinalis L. Fitoterapia. 82:414–421.
  • Musazzi L, Treccani G, Mallei A, Popoli M. 2013. The action of antidepressants on the glutamate system: regulation of glutamate release and glutamate receptors. Biol Psychiatry. 73:1180–1188.
  • Nations KR, Dogterom P, Bursi R, Schipper J, Greenwald S, Zraket D, Gertsik L, Johnstone J, Lee A, Pande Y, et al. 2012. Examination of Org 26576, an AMPA receptor positive allosteric modulator, in patients diagnosed with major depressive disorder: an exploratory, randomized, double-blind, placebo-controlled trial. J Psychopharmacol. 26:1525–1539.
  • Nguyen L, Matsumoto RR. 2015. Involvement of AMPA receptors in the antidepressant-like effects of dextromethorphan in mice. Behav Brain Res. 295:26–34.
  • Nie X, Shi B, Ding Y, Tao W. 2006. Preparation of a chemically sulfated polysaccharide derived from Grifola frondosa and its potential biological activities. Int J Biol Macromol. 39:228–233.
  • Okazaki M, Adachi Y, Ohno N, Yadomae T. 1995. Structure-activity relationship of (1->3)-beta-D-glucans in the induction of cytokine production from macrophages, in vitro. Biol Pharm Bull. 18:1320–1327.
  • Pilc A, Wieronska JM, Skolnick P. 2013. Glutamate-based antidepressants: preclinical psychopharmacology. Biol Psychiatry. 73:1125–1132.
  • Porsolt RD. 2000. Animal models of depression: utility for transgenic research. Rev Neurosci. 11:53–58.
  • Porsolt RD, Le Pichon M, Jalfre M. 1977. Depression: a new animal model sensitive to antidepressant treatments. Nature. 266:730–732.
  • Sanacora G, Treccani G, Popoli M. 2012. Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology. 62:63–77.
  • Sanzen I, Imanishi N, Takamatsu N, Konosu S, Mantani N, Terasawa K, Tazawa K, Odaira Y, Watanabe M, Takeyama M, et al. 2001. Nitric oxide-mediated antitumor activity induced by the extract from Grifola frondosa (Maitake mushroom) in a macrophage cell line, RAW264.7. J Exp Clin Cancer Res. 20:591–597.
  • Shen KP, Su CH, Lu TM, Lai MN, Ng LT. 2015. Effects of Grifola frondosa non-polar bioactive components on high-fat diet fed and streptozotocin-induced hyperglycemic mice. Pharm Biol. 53:705–709.
  • Shigesue K, Kodama N, Nanba H. 2000. Effects of maitake (Grifola frondosa) polysaccharide on collagen-induced arthritis in mice. Jpn J Pharmacol. 84:293–300.
  • Steru L, Chermat R, Thierry B, Simon P. 1985. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl). 85:367–370.
  • Tong H, Xia F, Feng K, Sun G, Gao X, Sun L, Jiang R, Tian D, Sun X. 2009. Structural characterization and in vitro antitumor activity of a novel polysaccharide isolated from the fruiting bodies of Pleurotus ostreatus. Bioresour Technol. 100:1682–1686.
  • Vickers A. 2002. Botanical medicines for the treatment of cancer: rationale, overview of current data, and methodological considerations for phase I and II trials. Cancer Invest. 20:1069–1079.